Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
XSign in

Market Pulse

Daily · Oct 13, 2026 · data.go.kr + ECOS
KOSPI
6,035.35
-348.89 (-5.46%)
KOSDAQ
837.03
-12.16 (-1.43%)
KOSPI 200
942.07
-62.85 (-6.25%)
USD/KRW
1,345.10
Home›Reports›069620
069620KOSPI·May 27, 2026

Initiating Coverage: New Business Potential; Discount to Narrow

DAEWOONG PHARMAKB SecuritiesJihoon Shin

KB Securities published a company analysis report on DAEWOONG PHARMA (069620) titled "Initiating Coverage: New Business Potential; Discount to Narrow".

Summary
Covers DAEWOONG PHARMA (069620).
Covered stock
069620
DAEWOONG PHARMA
KOSPI · Company analysis
Stock page →
More on 069620
Early Nabota shipments lift earningsMirae Asset Securities · Jul 31, 2026Efforts to streamline prescription drug channels underwayMirae Asset Securities · May 14, 2026Compelling valuationMirae Asset Securities · Nov 10, 2025Strong margin growthMirae Asset Securities · Feb 11, 2025
KOSPI
Initiating Coverage: New Business Potential; Discount to Narrow
KB Securities
DAEWOONG PHARMA logo
Source
KB Securities
PDF
Open report PDF →
Report facts
BrokerKB Securities
AnalystJihoon Shin
Publication dateMay 27, 2026
RatingBuy
Target priceKRW 210,000
CollectedJun 03, 2026
Use the publisher link for the complete report. Korean Tickers shows report metadata and a short overview.

Advertisement

Korean Tickers·Research reference for Korean listed companies.
API overviewPricingDocumentationPlan & billing
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy